Annual CFO
-$19.97 M
+$1.12 M+5.32%
December 31, 2023
Summary
- As of March 6, 2025, CASI annual cash flow from operations is -$19.97 million, with the most recent change of +$1.12 million (+5.32%) on December 31, 2023.
- During the last 3 years, CASI annual CFO has risen by +$5.92 million (+22.87%).
- CASI annual CFO is now -807.59% below its all-time high of -$2.20 million, reached on December 31, 1996.
Performance
CASI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
N/A
September 1, 2024
Summary
- CASI quarterly cash flow from operations is not available.
Performance
CASI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
N/A
September 1, 2024
Summary
- CASI TTM cash flow from operations is not available.
Performance
CASI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CASI Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.3% | - | - |
3 y3 years | +22.9% | - | - |
5 y5 years | +30.1% | - | - |
CASI Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +25.6% | ||||
5 y | 5-year | at high | +25.6% | ||||
alltime | all time | -807.6% | +62.2% |
CASI Pharmaceuticals Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$19.97 M(-5.3%) | - | - |
Dec 2022 | -$21.09 M(-21.4%) | -$843.00 K(-87.1%) | -$21.09 M(-24.4%) |
Sep 2022 | - | -$6.52 M(-31.2%) | -$27.89 M(+10.6%) |
Jun 2022 | - | -$9.48 M(+123.8%) | -$25.22 M(+9.3%) |
Mar 2022 | - | -$4.24 M(-44.5%) | -$23.08 M(-14.0%) |
Dec 2021 | -$26.84 M(+3.7%) | -$7.64 M(+98.0%) | -$26.84 M(-1.4%) |
Sep 2021 | - | -$3.86 M(-47.4%) | -$27.23 M(-9.8%) |
Jun 2021 | - | -$7.34 M(-8.3%) | -$30.20 M(+3.2%) |
Mar 2021 | - | -$8.00 M(-0.4%) | -$29.25 M(+13.0%) |
Dec 2020 | -$25.89 M(+11.4%) | -$8.03 M(+17.6%) | -$25.89 M(+14.2%) |
Sep 2020 | - | -$6.83 M(+6.9%) | -$22.67 M(+10.1%) |
Jun 2020 | - | -$6.39 M(+37.9%) | -$20.59 M(-9.1%) |
Mar 2020 | - | -$4.63 M(-3.8%) | -$22.66 M(-2.5%) |
Dec 2019 | -$23.24 M(-18.7%) | -$4.82 M(+1.5%) | -$23.24 M(-30.8%) |
Sep 2019 | - | -$4.75 M(-43.9%) | -$33.57 M(+2.0%) |
Jun 2019 | - | -$8.46 M(+62.2%) | -$32.92 M(+18.3%) |
Mar 2019 | - | -$5.22 M(-65.6%) | -$27.83 M(-2.6%) |
Dec 2018 | -$28.58 M(+346.5%) | -$15.15 M(+270.1%) | -$28.58 M(+93.2%) |
Sep 2018 | - | -$4.09 M(+21.1%) | -$14.79 M(+20.5%) |
Jun 2018 | - | -$3.38 M(-43.4%) | -$12.27 M(+13.2%) |
Mar 2018 | - | -$5.97 M(+340.3%) | -$10.84 M(+69.3%) |
Dec 2017 | -$6.40 M(+6.3%) | -$1.36 M(-13.8%) | -$6.40 M(-3.3%) |
Sep 2017 | - | -$1.57 M(-19.2%) | -$6.62 M(-1.1%) |
Jun 2017 | - | -$1.95 M(+27.1%) | -$6.69 M(+9.5%) |
Mar 2017 | - | -$1.53 M(-2.8%) | -$6.11 M(+1.5%) |
Dec 2016 | -$6.02 M(+9.2%) | -$1.57 M(-4.3%) | -$6.02 M(+4.9%) |
Sep 2016 | - | -$1.65 M(+20.7%) | -$5.74 M(+2.2%) |
Jun 2016 | - | -$1.36 M(-5.4%) | -$5.62 M(-2.2%) |
Mar 2016 | - | -$1.44 M(+11.6%) | -$5.74 M(+4.2%) |
Dec 2015 | -$5.51 M(+38.0%) | -$1.29 M(-15.2%) | -$5.51 M(+3.6%) |
Sep 2015 | - | -$1.52 M(+2.2%) | -$5.32 M(+10.3%) |
Jun 2015 | - | -$1.49 M(+23.1%) | -$4.82 M(+11.8%) |
Mar 2015 | - | -$1.21 M(+9.9%) | -$4.32 M(+8.0%) |
Dec 2014 | -$4.00 M(+22.0%) | -$1.10 M(+7.5%) | -$4.00 M(+10.7%) |
Sep 2014 | - | -$1.02 M(+4.5%) | -$3.61 M(-8.9%) |
Jun 2014 | - | -$980.40 K(+10.1%) | -$3.96 M(-1.6%) |
Mar 2014 | - | -$890.10 K(+24.7%) | -$4.03 M(+22.9%) |
Dec 2013 | -$3.28 M(+48.1%) | -$714.00 K(-48.1%) | -$3.28 M(-0.4%) |
Sep 2013 | - | -$1.38 M(+31.5%) | -$3.29 M(+5.0%) |
Jun 2013 | - | -$1.05 M(+647.9%) | -$3.13 M(-5.1%) |
Mar 2013 | - | -$139.90 K(-80.7%) | -$3.30 M(+49.1%) |
Dec 2012 | -$2.21 M(-48.2%) | -$726.30 K(-40.4%) | -$2.21 M(-7.5%) |
Sep 2012 | - | -$1.22 M(+0.3%) | -$2.39 M(-19.2%) |
Jun 2012 | - | -$1.21 M(-228.3%) | -$2.96 M(-21.8%) |
Mar 2012 | - | $946.80 K(-204.6%) | -$3.79 M(-11.3%) |
Dec 2011 | -$4.27 M(-13.9%) | -$905.50 K(-49.4%) | -$4.27 M(-7.8%) |
Sep 2011 | - | -$1.79 M(-12.4%) | -$4.63 M(-7.4%) |
Jun 2011 | - | -$2.04 M(-541.1%) | -$5.00 M(-4.3%) |
Mar 2011 | - | $462.70 K(-136.5%) | -$5.23 M(+5.5%) |
Dec 2010 | -$4.96 M(-51.4%) | -$1.27 M(-41.3%) | -$4.96 M(-7.3%) |
Sep 2010 | - | -$2.16 M(-4.8%) | -$5.35 M(-15.7%) |
Jun 2010 | - | -$2.27 M(-409.2%) | -$6.34 M(-19.3%) |
Mar 2010 | - | $733.40 K(-144.3%) | -$7.86 M(-23.0%) |
Dec 2009 | -$10.21 M | -$1.66 M(-47.5%) | -$10.21 M(-1.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2009 | - | -$3.15 M(-16.8%) | -$10.38 M(-27.6%) |
Jun 2009 | - | -$3.79 M(+134.6%) | -$14.34 M(-20.7%) |
Mar 2009 | - | -$1.62 M(-11.5%) | -$18.08 M(-12.7%) |
Dec 2008 | -$20.71 M(-11.9%) | -$1.83 M(-74.3%) | -$20.71 M(-8.1%) |
Sep 2008 | - | -$7.11 M(-5.5%) | -$22.54 M(+0.5%) |
Jun 2008 | - | -$7.52 M(+76.9%) | -$22.43 M(-3.5%) |
Mar 2008 | - | -$4.25 M(+16.5%) | -$23.24 M(-1.2%) |
Dec 2007 | -$23.52 M(+13.2%) | -$3.65 M(-47.9%) | -$23.52 M(-4.9%) |
Sep 2007 | - | -$7.00 M(-15.9%) | -$24.73 M(+5.6%) |
Jun 2007 | - | -$8.33 M(+83.7%) | -$23.43 M(+18.0%) |
Mar 2007 | - | -$4.54 M(-6.6%) | -$19.85 M(-4.4%) |
Dec 2006 | -$20.77 M(+43.1%) | -$4.86 M(-14.7%) | -$20.77 M(+6.1%) |
Sep 2006 | - | -$5.70 M(+19.8%) | -$19.57 M(+8.2%) |
Jun 2006 | - | -$4.76 M(-12.8%) | -$18.09 M(-5.1%) |
Mar 2006 | - | -$5.46 M(+49.1%) | -$19.05 M(+31.2%) |
Dec 2005 | -$14.52 M(-11.5%) | -$3.66 M(-13.2%) | -$14.52 M(+9.3%) |
Sep 2005 | - | -$4.21 M(-26.4%) | -$13.28 M(+5.0%) |
Jun 2005 | - | -$5.72 M(+519.7%) | -$12.65 M(+13.2%) |
Mar 2005 | - | -$923.40 K(-61.9%) | -$11.18 M(-31.9%) |
Dec 2004 | -$16.41 M(-32.3%) | -$2.42 M(-32.4%) | -$16.41 M(-3.9%) |
Sep 2004 | - | -$3.58 M(-15.7%) | -$17.07 M(-2.3%) |
Jun 2004 | - | -$4.25 M(-30.9%) | -$17.48 M(-15.5%) |
Mar 2004 | - | -$6.15 M(+99.4%) | -$20.68 M(-14.7%) |
Dec 2003 | -$24.25 M(-46.7%) | -$3.08 M(-22.7%) | -$24.25 M(-0.9%) |
Sep 2003 | - | -$3.99 M(-46.5%) | -$24.46 M(-8.5%) |
Jun 2003 | - | -$7.45 M(-23.3%) | -$26.72 M(-23.3%) |
Mar 2003 | - | -$9.72 M(+195.2%) | -$34.83 M(-23.5%) |
Dec 2002 | -$45.53 M(-13.9%) | -$3.29 M(-47.4%) | -$45.53 M(-23.6%) |
Sep 2002 | - | -$6.25 M(-59.8%) | -$59.58 M(-7.6%) |
Jun 2002 | - | -$15.56 M(-23.8%) | -$64.48 M(+4.3%) |
Mar 2002 | - | -$20.42 M(+17.8%) | -$61.81 M(+16.9%) |
Dec 2001 | -$52.87 M(+19.5%) | -$17.34 M(+55.5%) | -$52.87 M(+18.2%) |
Sep 2001 | - | -$11.16 M(-13.5%) | -$44.75 M(-0.4%) |
Jun 2001 | - | -$12.89 M(+12.3%) | -$44.94 M(+4.0%) |
Mar 2001 | - | -$11.48 M(+24.6%) | -$43.21 M(-2.3%) |
Dec 2000 | -$44.25 M(+23.6%) | -$9.22 M(-18.8%) | -$44.25 M(-8.1%) |
Sep 2000 | - | -$11.35 M(+1.7%) | -$48.13 M(+8.0%) |
Jun 2000 | - | -$11.16 M(-10.9%) | -$44.55 M(+7.4%) |
Mar 2000 | - | -$12.52 M(-4.4%) | -$41.47 M(+15.9%) |
Dec 1999 | -$35.80 M(+186.4%) | -$13.10 M(+68.5%) | -$35.80 M(+39.3%) |
Sep 1999 | - | -$7.77 M(-3.8%) | -$25.70 M(+16.2%) |
Jun 1999 | - | -$8.08 M(+18.0%) | -$22.13 M(+45.1%) |
Mar 1999 | - | -$6.85 M(+128.3%) | -$15.25 M(+22.0%) |
Dec 1998 | -$12.50 M(+89.4%) | -$3.00 M(-28.6%) | -$12.50 M(+23.8%) |
Sep 1998 | - | -$4.20 M(+250.0%) | -$10.10 M(+13.5%) |
Jun 1998 | - | -$1.20 M(-70.7%) | -$8.90 M(+6.0%) |
Mar 1998 | - | -$4.10 M(+583.3%) | -$8.40 M(+27.3%) |
Dec 1997 | -$6.60 M(+200.0%) | -$600.00 K(-80.0%) | -$6.60 M(0.0%) |
Sep 1997 | - | -$3.00 M(+328.6%) | -$6.60 M(+15.8%) |
Jun 1997 | - | -$700.00 K(-69.6%) | -$5.70 M(+119.2%) |
Mar 1997 | - | -$2.30 M(+283.3%) | -$2.60 M(+18.2%) |
Dec 1996 | -$2.20 M | -$600.00 K(-71.4%) | -$2.20 M(+37.5%) |
Sep 1996 | - | -$2.10 M(-187.5%) | -$1.60 M(-420.0%) |
Jun 1996 | - | $2.40 M(-226.3%) | $500.00 K(-126.3%) |
Mar 1996 | - | -$1.90 M | -$1.90 M |
FAQ
- What is CASI Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual CFO year-on-year change?
- What is the all time high quarterly CFO for CASI Pharmaceuticals?
- What is the all time high TTM CFO for CASI Pharmaceuticals?
What is CASI Pharmaceuticals annual cash flow from operations?
The current annual CFO of CASI is -$19.97 M
What is the all time high annual CFO for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual cash flow from operations is -$2.20 M
What is CASI Pharmaceuticals annual CFO year-on-year change?
Over the past year, CASI annual cash flow from operations has changed by +$1.12 M (+5.32%)
What is the all time high quarterly CFO for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly cash flow from operations is $2.40 M
What is the all time high TTM CFO for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high TTM cash flow from operations is $500.00 K